Arrow Int’l revamps sales
This article was originally published in The Gray Sheet
Executive Summary
Following former Group Vice President-Critical Care and head of U.S. sales and marketing Philip Croxford's departure from the company, sales reps are "reporting to me directly now," said CEO Carl Anderson during a fiscal first quarter 2006 call. The firm does not plan to hire a replacement for Croxford's position. The firm brought in $113.6 mil. during the quarter, up 2% over the prior-year period, but missed its internal guidance by 1.2%-3%. The firm anticipates revenue of $117-$120 mil. for Q2. New manufacturing plants in Mexico and the Czech Republic are on track to begin catheter production this year (1"The Gray Sheet" Oct. 10, 2005, p. 13)...